n-butyl glyoxylate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: n-butyl glyoxylate
• 英文别名: Pentyl 2-oxoacetate
• 化学式: C₇H₁₂O₃
• 分子量: 144.17
• InChiKey: JLXKKJMDDIHVAH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  10
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  巯基乙胺 、 n-butyl glyoxylate 生成 (2-Amino-ethylsulfanyl)-hydroxy-acetic acid pentyl ester
  参考文献：
  名称：

  Fourneau,J.-P. et al., Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1971, vol. 272, p. 1515 - 1517

  摘要：

  DOI：
• 作为产物：
  描述：

  dibutyl tartrate 在 periodic acid dihydrate 作用下， 以 乙醚 为溶剂， 反应 6.0h， 以86%的产率得到n-butyl glyoxylate
  参考文献：
  名称：

  合成获得的所有4种氧黄素立体异构体

  摘要：

  描述了3-氨基-2-氧杂环丁烷羧酸（oxetin）的所有四个立体异构体的简短合成。氧杂环丁烷核心是使用Paternò–Büchi光化学[2 + 2]环加成反应构建的；从关键中间体开始，补充拆分方案可提供对映体纯的oxetin和epi -oxetin的克级分析方法。

  DOI：

  10.1021/acs.joc.6b01795

文献信息

• Catalyst for decarbonylation reaction
  申请人：UBE INDUSTRIES, LTD.

  公开号：EP0826658A1

  公开（公告）日：1998-03-04

  A catalyst composed of an organic phosphorus compound having a trivalent or pentavalent phosphorus atom and at least one carbon-phosphorus bonding or a combination of the organic phosphorus compound and a halogen atom-containing compound is effective for decarbonylation, that is, for releasing carbon monoxide from a compound containing a moiety of -CO-CO-O- in its molecular structure.

  一种由含有三价或五价磷原子的有机磷化合物和至少一个碳-磷键合或有机磷化合物与含卤原子的化合物的组合构成的催化剂对于脱羰基作用是有效的，即从含有分子结构中的-CO-CO-O-基团的化合物中释放一氧化碳。
• [EN] POLYCYCLIC GLYOXYLATES AS PHOTOINITIATORS<br/>[FR] GLYOXYLATES POLYCYCLIQUES UTILISÉS EN TANT QUE PHOTO-INITIATEURS
  申请人：IGM GROUP B V

  公开号：WO2018041935A1

  公开（公告）日：2018-03-08

  The present invention relates to photoinitiator compounds of the formula (1) wherein X is O, S or a direct bond; Y is O, S or CR9R10; R1, R2, R3, R4, R5, R6, R7 and R8 independently of each other are hydrogen, halogen, C1- C18alkyl, C5-C10cycloalkyl, C2-C18alkenyl, phenyl, C1-C4alkoxy, C5-C7cycloalkoxy, phenoxy, C1-C4-alkylthio, C5-C7cycloalkylthio, phenylthio, di(C1-C4alkyl)amino, di(C5-C7cycloalkyl)amino, N-morpholinyl, N-piperidinyl or a group of formula (2) provided that one or more than one of R1, R2, R3, R4, R5, R6, R7 or R8 is a group of formula (2); R9, R10 independently of each other are hydrogen, C1-C18alkyl, C2-C12alkenyl, C5-C10cycloalkyl, phenyl-C1-C4alkyl, phenyl or together with the C atom to which they are attached form a 5-membered, 6-membered or 7-membered ring; and R11 is hydrogen, C1-C18alkyl, C5-C10cycloalkyl, C2-C12alkenyl, phenyl-C1-C4alkyl or phenyl.

  本发明涉及式（1）的光引发剂化合物，其中X为O、S或直接键；Y为O、S或CR9R10；R1、R2、R3、R4、R5、R6、R7和R8彼此独立地为氢、卤素、C1-C18烷基、C5-C10环烷基、C2-C18烯基、苯基、C1-C4烷氧基、C5-C7环烷氧基、苯氧基、C1-C4烷硫基、C5-C7环烷硫基、苯硫基、二(C1-C4烷基)氨基、二(C5-C7环烷基)氨基、N-吗啉基、N-哌啶基或式（2）的基团，前提是R1、R2、R3、R4、R5、R6、R7或R8中的一个或多个是式（2）的基团；R9、R10彼此独立地为氢、C1-C18烷基、C2-C12烯基、C5-C10环烷基、苯基-C1-C4烷基、苯基或与它们连接的碳原子一起形成5、6或7元环；R11为氢、C1-C18烷基、C5-C10环烷基、C2-C12烯基、苯基-C1-C4烷基或苯基。
• Compounds having activity as inhibitors of cytochrome P450RAI
  申请人：——

  公开号：US20020193578A1

  公开（公告）日：2002-12-19

  Compounds having Formula 1 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids. 1

  化合物的化学式为1，其中符号的含义在规范中定义，是细胞色素P450RAI（诱导维甲酸）酶的抑制剂，用于治疗对维甲酸类药物治疗敏感的疾病。
• Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
  申请人：——

  公开号：US20030078270A1

  公开（公告）日：2003-04-24

  Novel compounds having the Formulas 1 through 8, wherein the symbols have the meaning defined in the specification, and certain previously known compounds have been discovered to act as inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids. The compound can also be used in co-treatment with retinoids. 1

  具有1到8式的新化合物已被发现可以作为细胞色素P450RAI（诱导维甲酸）酶的抑制剂，并用于治疗对维甲酸类治疗有反应的疾病。该化合物还可与维甲酸类药物共同治疗。其中符号的含义在说明中定义。
• 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF
  申请人：Pfister Jürg R.

  公开号：US20120029044A1

  公开（公告）日：2012-02-02

  Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetylcholine receptor-mediated diseases, such as pulmonary diseases, are provided.

  本发明提供了肌动蛋白乙酰胆碱受体拮抗剂及其用于治疗肺部疾病等肌动蛋白乙酰胆碱受体介导疾病的方法。